Qiagen (Nasdaq: QGEN) is expected to report Q3 earnings on Oct. 29. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Qiagen's revenues will expand 5.5% and EPS will grow 8.3%.

The average estimate for revenue is $304.7 million. On the bottom line, the average EPS estimate is $0.26.

Revenue details
 Last quarter, Qiagen tallied revenue of $307.2 million. GAAP reported sales were 8.9% higher than the prior-year quarter's $282.2 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at $0.25. GAAP EPS of $0.14 were the same as the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 66.1%, 70 basis points worse than the prior-year quarter. Operating margin was 16.8%, 30 basis points better than the prior-year quarter. Net margin was 10.9%, 90 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $1.24 billion. The average EPS estimate is $1.05.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 110 members out of 121 rating the stock outperform, and 11 members rating it underperform. Among 35 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 32 give Qiagen a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Qiagen is hold, with an average price target of $17.33.